← Oncology Approval Tracker

FDA DECISION ·

Jelmyto

mitomycin · UroGen Pharma

FDA approvalNew formulationUpper tract urothelial cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with low-grade upper tract urothelial cancer.

LAMPGEN ANALYSIS

Why it matters

Made local mitomycin delivery possible with a gel designed to remain in the upper urinary tract.

What research teams should watch

Confirm tumor grade and plan administration and follow-up for ureteral obstruction.

PRIMARY RECORDS

Sources